XBIT
XBIT
NASDAQ · Biotechnology

Xbiotech Inc

$2.37
+0.07 (+3.04%)
As of Feb 8, 2:14 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +405.1% upside
Low Target $8.96
Average Target $11.97
High Target $15.34
Current Price $2.37
Current
$2.37
Target
$11.97
$8.96 $11.97 avg $15.34
Scenario Analysis
Bear Case
$8.96
278.1%
Low target
Base Case
$11.97
+405.1%
Avg target
Bull Case
$15.34
+547.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$13.28
-82.2% from high
52-Week Low
$7.14
+-66.8% from low
Target vs 52W High
$11.97
-9.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%